Melanóma: vizsgálatok itt: Ukrajna
4 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1. fázisTaking peoplePharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma
- Where
- Ivano-Frankivsk, Kyiv
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Biocon Biologics UK PLC
See details and how to joinNCT07476326 · EU 2025-525158-20-00 - 3. fázisTaking peopleStudy to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma
- Where
- Chernivtsi, Ivano-Frankivsk, Kyiv, Lutsk, Ternopil, Uzhhorod, Vinnytsia
- Életkor
- 18 év and over
- People
- 632 worldwide
- Run by
- mAbxience Research S.L.
See details and how to joinNCT07221734 - 1. fázisTaking peoplePharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma
- Where
- Kiev
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Alvotech Swiss AG
See details and how to joinNCT07475572 · EU 2025-525093-11-00 - 1/2. fázisTaking peopleSafety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms
- Where
- Kropyvnytskyi, Kyiv
- Életkor
- 18 év and over
- People
- 36
- Run by
- Vector Vitale LLC
See details and how to joinNCT06506643